The Big 3: PFE, V, SYF

The Schwab Network's 'Big Three' segment delivers a high-conviction trio of stock picks amid a market surging to all-time highs, with Dan Deming of KKM Financial arguing that Pfizer, Visa, and Synchrony are poised for recovery driven by technical breakouts and strategic options plays. Despite a recent pullback, Pfizer's rebound from 2670 to 2730 is seen as a compelling entry point, with a covered call strategy targeting June 29 expiration to generate yield while capturing upside. Visa, after a 10% YTD decline and a sharp sell-off, shows clear signs of bottoming and trend reversal, with a bullish call spread paired with a protective put to hedge earnings risk. Synchrony, though less liquid, is highlighted for its narrow upward channel and recent gap fill, with a June 85 call write offering yield and exit clarity near January highs. The episode underscores a tactical shift toward defensive sectors with strong technical momentum and options-based risk management. The core thesis isn't just about individual stock strength, but about identifying structural rebounds in names that were oversold during broader market volatility. Deming’s trades are designed to profit from both short-term catalysts—like earnings—and longer-term uptrends, using options to generate income and define exit points. This approach reflects a disciplined, data-driven strategy that prioritizes technical confirmation over sentiment, especially in a market where momentum is king. The episode’s real insight?